Main Menu

• Home
• About Us
  • The Company
  • Key People
    • Management Team
      • Elisha Yelin - CEO
      • Dr. Lev Diamant - CTO
      • Itshak Israel - VP Business Development
      • Inbar Babad - CFO
      • Iris Menachem - COO
    • Board of Directors
      • Yossi Tamar (COB)
      • Dr. Yehoshua Gleitman
      • Limor Sela
      • Dr. Shmuel Cabili
      • Prof. Yehuda Kahane
      • Sefi Ratz
    • Investment Committee
      • Yossi Tamar
      • Dr. Yehoshua Gleitman
      • Prof. Yehuda Kahane
      • Dr. Shmuel Cabilli
      • Uri Meir
      • Shay Lior Israel
      • Itshak Israel
    • Elisha Yelin - CEO
    • Dr. Lev Diamant - CTO
    • Itshak Israel - VP Business Development
    • Inbar Babad - CFO
    • Iris Menachem - COO
  • Success Stories
    • Lithotech Medical
    • Niti Surgical
    • Lextran
• Portfolio
  • Medical Devices
  • Life Sciences
  • Cleantech
  • Information Technology
• For Entrepreneurs
• Partners
• News
  • News
    • WiFun TV Approved by Chief Scientist
    • Dermipsor Succeeds in Phase II
    • Lextran Signs Chinese Contract
    • Biocep Raises 525 Thousand Dollars
    • LRS Ortho Starts Sales
    • Coeruleus Completes Stage I Clinical Studies
    • Spinal Balloon incubated in Meytag
    • LRS completed successful clinical trials in orthopedic surgeries
  • Events
    • Meytag in the Botechnology Exposition
  • From the Press
    • Ynet: A new building for Meytag High Tech Ventures for 12 companies. Cost:7.5 Million Shekels
    • TheMarker: Capital Point completed full ownership of Meytag High Tech Ventures
  • WiFun TV Approved by Chief Scientist
  • Dermipsor Succeeds in Phase II
  • Lextran Signs Chinese Contract
  • Biocep Raises 525 Thousand Dollars
  • LRS Ortho Starts Sales
  • Coeruleus Completes Stage I Clinical Studies
  • Spinal Balloon incubated in Meytag
  • LRS completed successful clinical trials in orthopedic surgeries
• Contact Us